Acorn Campus Ventures
Signal active
Investment Firm
Overview
Acorn Campus Ventures is a venture capital fund that provides private equity investments to firms in the wireless, semiconductor, photonics, internet, and life sciences industries. It was founded by David Tsang and is based in California.
Highlights
Founded
2000
Industry
Venture Capital
Employees
11-50
Investment
16
Lead Investment
4
Exits
2
Stages
Early Stage Venture, Late Stage Venture
Investor Type
Venture Capital
Location
United States, North America
Contact Information
Social
Profile Resume
Acorn Campus Ventures, established in 2000 and headquartered in United States, North America., specializes in Early Stage Venture, Late Stage Venture investments across Biotechnology, Medical, Health Care, Medical Device, Financial Services, Venture Capital, Finance, Software, Semiconductor, Electronics. The organization boasts a portfolio of 16 investments, with an average round size of $13.5M and 2 successful exits. Their recent investments include AutekBio, Optovue, H&Q Asia Pacific, Harbinger Ventures, Trevi Health Ventures. The highest investment round they participated in was $8.1B. Among their most notable exits are AutekBio and Optovue. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
Acorn Campus Ventures has made 16 investments. Their most recent investment was on Sep 23, 2014, when Eureka Therapeutics raised $21.0M.
investments
16
Diversity investments
1
Lead investments
4
Number of exits
2
Investments
16
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Nov 13, 2008 | Eureka Therapeutics | Biotechnology | 1.7M |
| Aug 21, 2012 | Waterstone Pharmaceuticals | Biotechnology | 3.4M |
| Sep 23, 2014 | Eureka Therapeutics | Biotechnology | 21.0M |
| Nov 30, 2017 | - | - | null |
Waterstone PharmaceuticalsExits
2
Funding Timeline
Funding rounds
16
Investors
0
Funds
1
Funding Rounds
16
Acorn Campus Ventures has raised 16 rounds. Their latest funding was raised on Nov 30, 2017 from a Series A - Flat Medical round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Nov 13, 2008 | Series B - Eureka Therapeutics | - | 1.7M | - |
| Aug 21, 2012 | Series B - Waterstone Pharmaceuticals | - | 3.4M | - |
| Sep 23, 2014 | Series C - Eureka Therapeutics | - | 21.0M | - |
| Nov 30, 2017 | Series A - Flat Medical | - | 0 | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.